Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3828)
All Articles published online
|
Feb 21, 2008 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jakob C, Liersch T, Meyer W, Becker H, Baretton GB, Aust DE. Predictive value of Ki67 and p53 in locally advanced rectal cancer: Correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy. World J Gastroenterol 2008; 14(7): 1060-1066 [PMID: 18286688 DOI: 10.3748/wjg.14.1060] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i7/1060.htm |
| Number | Citing Articles |
| 1 |
Sarah A. Milgrom, Julio Garcia-Aguilar. Molecular biomarkers as predictors of response to neoadjuvant chemoradiation therapy in rectal cancer. Seminars in Colon and Rectal Surgery 2013; 24(3): 119 doi: 10.1053/j.scrs.2013.03.003
|
| 2 |
Yifan Peng, Lin Wang, Jin Gu. Elevated Preoperative Carcinoembryonic Antigen (CEA) and Ki67 Is Predictor of Decreased Survival in IIA Stage Colon Cancer. World Journal of Surgery 2013; 37(1): 208 doi: 10.1007/s00268-012-1814-7
|
| 3 |
Hyuk Hur, Nam Kyu Kim, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Woong Sub Koom, Joong Bae Ahn, Hoguen Kim. Can a Biomarker-Based Scoring System Predict Pathologic Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer?. Diseases of the Colon & Rectum 2014; 57(5): 592 doi: 10.1097/DCR.0000000000000109
|
| 4 |
KENTARO NAKAMOTO, HISASHI NAGAHARA, KIYOSHI MAEDA, EIJI NODA, TORU INOUE, MASAKAZU YASHIRO, YUKIO NISHIGUCHI, MASAICHI OHIRA, KOSEI HIRAKAWA. Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer. Oncology Letters 2013; 5(4): 1295 doi: 10.3892/ol.2013.1187
|
| 5 |
Sergio Huerta, Xiaohuan Gao, Debabrata Saha. Mechanisms of resistance to ionizing radiation in rectal cancer. Expert Review of Molecular Diagnostics 2009; 9(5): 469 doi: 10.1586/erm.09.26
|
| 6 |
Lin Xiao, Xin Yu, Rong Zhang, Hui Chang, Shaoyan Xi, Weiwei Xiao, Zhifan Zeng, Huizhong Zhang, Ruihua Xu, Yuanhong Gao. Can anIL13-1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?. Oncotarget 2016; 7(23): 34149 doi: 10.18632/oncotarget.9178
|
| 7 |
Tobias Leibold, Vanessa W. Hui, Jinru Shia, Jeannine A. Ruby, Elyn R. Riedel, José G. Guillem. p27 expression in post-treatment rectal cancer: a potential novel approach for predicting residual nodal disease. The American Journal of Surgery 2014; 208(2): 228 doi: 10.1016/j.amjsurg.2014.02.003
|
| 8 |
Jeffrey G. Kuremsky, Joel E. Tepper, Howard L. McLeod. Biomarkers for Response to Neoadjuvant Chemoradiation for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 2009; 74(3): 673 doi: 10.1016/j.ijrobp.2009.03.003
|
| 9 |
Sarah Brophy, Katherine M. Sheehan, Deborah A. McNamara, Joseph Deasy, David J. Bouchier‐Hayes, Elaine W. Kay. GLUT‐1 expression and response to chemoradiotherapy in rectal cancer. International Journal of Cancer 2009; 125(12): 2778 doi: 10.1002/ijc.24693
|
| 10 |
David Páez, Laia Paré, Albert Altés, Francesc Josep Sancho-Poch, Lourdes Petriz, Jordi Garriga, Josep Maria Monill, Juliana Salazar, Elisabeth del Rio, Agustí Barnadas, Eugenio Marcuello, Montserrat Baiget. Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil. Journal of Cancer Research and Clinical Oncology 2010; 136(11): 1681 doi: 10.1007/s00432-010-0826-7
|
| 11 |
Giampietro Gasparini, Francesco Torino, Takayuki Ueno, Stefano Cascinu, Teresa Troiani, Alberto Ballestrero, Rossana Berardi, Junichi Shishido, Akihiko Yoshizawa, Yukiko Mori, Satoshi Nagayama, Paola Morosini, Masakazu Toi. A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. Angiogenesis 2012; 15(1): 141 doi: 10.1007/s10456-011-9250-0
|
| 12 |
Lena-Christin Conradi, Annalen Bleckmann, Markus Schirmer, Thilo Sprenger, Peter Jo, Kia Homayounfar, Hendrik A. Wolff, Hilka Rothe, Peter Middel, Heinz Becker, Michael B. Ghadimi, Tim Beissbarth, Torsten Liersch. Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment. Annals of Surgical Oncology 2011; 18(9): 2442 doi: 10.1245/s10434-011-1608-4
|
| 13 |
María Moral, Ma Jesús Fdez-Aceñero, Rosa Cuberes, Angel Suárez. Factors influencing histological response after neoadjuvant chemoradiation therapy for rectal carcinoma. Pathology - Research and Practice 2009; 205(10): 695 doi: 10.1016/j.prp.2009.04.006
|
| 14 |
Rasa Purvinienė, Nijolė Kazlauskaitė, Vydmantas Atkočius, Dainius Characiejus, Aloyza Lukšienė. Relationship between growth fraction and clonogenic survival after ionizing irradiation in pancreatic MiaPaCa2 cells. Acta medica Lituanica 2009; 16(1): 42 doi: 10.2478/v10140-009-0006-8
|
| 15 |
Jung Wook Huh, Woo Yong Lee, Seok Hyung Kim, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Hee Chul Park, Doo Ho Choi, Joon Oh Park, Young Suk Park, Ho-Kyung Chun. Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis. Yonsei Medical Journal 2015; 56(1): 82 doi: 10.3349/ymj.2015.56.1.82
|
| 16 |
Shuxuan Fan, Xubin Li, Lei Zheng, Dongzhi Hu, Xiaoyi Ren, Zhaoxiang Ye. Correlations between the iodine concentrations from dual energy computed tomography and molecular markers Ki-67 and HIF-1α in rectal cancer: A preliminary study. European Journal of Radiology 2017; 96: 109 doi: 10.1016/j.ejrad.2017.08.026
|
| 17 |
Zhiwei Zhang, Xiyun Deng, Xiubao Ren, Benning Zhang, Xiaodan Chen, Jinyan Yang, Haiyan Ding, Jun Sui, Xin Song. Expression of mutant p53 and of the multidrug resistant proteins P-glycoprotein and glutathione S-transferase-pi correlated in colorectal adenocarcinoma. Scandinavian Journal of Gastroenterology 2010; 45(7-8): 925 doi: 10.3109/00365521003734117
|
| 18 |
Takashi Akiyoshi, Takashi Kobunai, Toshiaki Watanabe. Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer. Surgery Today 2012; 42(8): 713 doi: 10.1007/s00595-012-0223-8
|
| 19 |
Melanie Kripp, Kirsten Merx, Ralph Markus Wirtz, Timo Gaiser, Sebastian Eidt, Juliana Schwaab, Stefan Post, Frederik Wenz, Andreas Hochhaus, Ralf-Dieter Hofheinz, Philipp Erben. Prognostic Impact of mRNA Expression Levels of HER1–4 (ERBB1–4) in Patients with Locally Advanced Rectal Cancer. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/3481578
|
| 20 |
Christine Koulis, Raymond Yap, Rebekah Engel, Thierry Jardé, Simon Wilkins, Gemma Solon, Jeremy D. Shapiro, Helen Abud, Paul McMurrick. Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer. Cancers 2020; 12(4): 812 doi: 10.3390/cancers12040812
|
| 21 |
Bishoy S. Fawzy, Mohamed S. Nafie, Ibrahim A. I. Ali, Lamis M. F. El‐Baz, Xueqing Xu, Mohamed A. Abdel-Rahman. Scorpion Venom Peptide Smp24 Revealed Apoptotic and Antiangiogenic Activities in Solid-Ehrlich Carcinoma Bearing Mice. International Journal of Peptide Research and Therapeutics 2023; 29(2) doi: 10.1007/s10989-023-10494-6
|
| 22 |
Gerald A Gantt, Matthew F Kalady. Molecular markers for targeted neoadjuvant rectal cancer therapy. Colorectal Cancer 2013; 2(4): 321 doi: 10.2217/crc.13.35
|
| 23 |
Rebecca Senetta, Eleonora Duregon, Cristina Sonetto, Rossella Spadi, Massimiliano Mistrangelo, Patrizia Racca, Luigi Chiusa, Fernando H. Munoz, Umberto Ricardi, Alberto Arezzo, Adele Cassenti, Isabella Castellano, Mauro Papotti, Mario Morino, Mauro Risio, Paola Cassoni, Jose G. Trevino. YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study. PLOS ONE 2015; 10(4): e0123759 doi: 10.1371/journal.pone.0123759
|
| 24 |
MASAFUMI INOMATA, TOMONORI AKAGI, KENTARO NAKAJIMA, TSUYOSHI ETOH, KOICHIRO TAHARA, TOSHIFUMI MATSUMOTO, TADASHI OGAWA, KYUZO FUJII, AKIO SHIROMIZU, SEIGO KITANO. A prospective feasibility study to evaluate neoadjuvant-synchronous S-1 with radiotherapy for locally advanced rectal cancer: A multicentre phase II trial. Molecular and Clinical Oncology 2016; 4(4): 510 doi: 10.3892/mco.2016.767
|
| 25 |
Xiangjiao Meng, Huijuan Li, Lingling Kong, Xianguang Zhao, Zhaoqin Huang, Hanxi Zhao, Wanqi Zhu, Xiaolin Li, Jinming Yu, Ligang Xing. MRI In rectal cancer: Correlations between MRI features and molecular markers Ki‐67, HIF‐1α, and VEGF. Journal of Magnetic Resonance Imaging 2016; 44(3): 594 doi: 10.1002/jmri.25195
|
| 26 |
Toshiyuki Suzuki, Sotaro Sadahiro, Akira Tanaka, Kazutake Okada, Hiroko Kamata, Akemi Kamijo, Chieko Murayama, Takeshi Akiba, Shuichi Kawada. Biopsy Specimens Obtained 7 Days After Starting Chemoradiotherapy (CRT) Provide Reliable Predictors of Response to CRT for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 2013; 85(5): 1232 doi: 10.1016/j.ijrobp.2012.09.031
|
| 27 |
Marian Grade, Jochen Gaedcke, Danny Wangsa, Sudhir Varma, Jaje Beckmann, Torsten Liersch, Clemens Hess, Heinz Becker, Michael J. Difilippantonio, Thomas Ried, B. Michael Ghadimi. Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy. Cancer Genetics and Cytogenetics 2009; 193(1): 19 doi: 10.1016/j.cancergencyto.2009.03.016
|
| 28 |
Ihsane El Otmani, Fatima El Agy, Sanae El Baradai, Laila Bouguenouch, Nada Lahmidani, Mohammed El Abkari, Dafr Allah Benajah, Imane Toughrai, Hicham El Bouhaddouti, Ouadii Mouaqit, Karim Ibn Majdoub Hassani, Khalid Mazaz, El Bachir Benjelloun, Abdelmalek Ousadden, Karima El Rhazi, Touria Bouhafa, Zineb Benbrahim, Karim Ouldim, Sidi Adil Ibrahimi, Khalid Ait Taleb, Laila Chbani. Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8459303
|
| 29 |
J.S. Tsang, S. Vencken, O. Sharaf, E. Leen, E.W. Kay, D.A. McNamara, J. Deasy, E.D. Mulligan. Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment – A pilot study. European Journal of Surgical Oncology (EJSO) 2014; 40(11): 1459 doi: 10.1016/j.ejso.2014.06.008
|
| 30 |
Kai M. Brown, Aiqun Xue, Sohel M. Julovi, Anthony J. Gill, Nick Pavlakis, Jaswinder S. Samra, Ross C. Smith, Thomas J. Hugh. Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity. Journal of Surgical Research 2018; 227: 158 doi: 10.1016/j.jss.2018.02.018
|
| 31 |
Alberto Izzotti, Chiara Ceccaroli, Marta Geretto, Filippo Grillo Ruggieri, Sara Schenone, Emilio Di Maria. Predicting Response to Neoadjuvant Therapy in Colorectal Cancer Patients the Role of Messenger-and Micro-RNA Profiling. Cancers 2020; 12(6): 1652 doi: 10.3390/cancers12061652
|
| 32 |
Milena Krajnović, Bojana Marković, Slavica Knežević-Ušaj, Ivan Nikolić, Maja Stanojević, Valentina Nikolić, Marina Šiljić, Snežana Jovanović Ćupić, Bogomir Dimitrijević. Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics. Pathology - Research and Practice 2016; 212(7): 598 doi: 10.1016/j.prp.2016.02.018
|
| 33 |
M. Zhou, H. Huang, Y. Fan, M. Chen, M. Li, Y. Wang. The application of quantitative perfusion analysis of golden-angle radial sparse parallel MRI and R2∗ value for predicting pathological prognostic factors in rectal cancer. Clinical Radiology 2024; 79(2): 124 doi: 10.1016/j.crad.2023.10.027
|
| 34 |
Alissa Greenbaum, David R. Martin, Thèrése Bocklage, Ji-Hyun Lee, Scott A. Ness, Ashwani Rajput. Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Clinical Colorectal Cancer 2019; 18(2): 102 doi: 10.1016/j.clcc.2019.02.003
|
| 35 |
Maura Boldrini, Mark D Underwood, René Hen, Gorazd B Rosoklija, Andrew J Dwork, J John Mann, Victoria Arango. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009; 34(11): 2376 doi: 10.1038/npp.2009.75
|
| 36 |
Chiara Molinari, Michela Ballardini, Nazario Teodorani, Massimo Giannini, Wainer Zoli, Ermanno Emiliani, Enrico Lucci, Alessandro Passardi, Paola Rosetti, Luca Saragoni, Massimo Guidoboni, Dino Amadori, Daniele Calistri. Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study. Radiation Oncology 2011; 6(1) doi: 10.1186/1748-717X-6-161
|
| 37 |
Yu R Aliyarov, L A Melikova, A Kh Kerimov, E E Bagirova, S G Mekhdizade. Role of thymidylate synthase as a predictor of neoadjuvant chemoradiation therapy in rectal cancer. Kazan medical journal 2017; 98(4): 576 doi: 10.17750/KMJ2017-576
|
| 38 |
Anna Gasinska, Agnieszka Adamczyk, Joanna Niemiec, Beata Biesaga, Zbigniew Darasz, Jan Skolyszewski. Gender-Related Differences in Pathological and Clinical Tumor Response Based on Immunohistochemical Proteins Expression in Rectal Cancer Patients Treated with Short Course of Preoperative Radiotherapy. Journal of Gastrointestinal Surgery 2014; 18(7): 1306 doi: 10.1007/s11605-014-2526-0
|
| 39 |
Murat Koç, Gamze Ç. Kaya, Yusuf Demir, Erdem Sürücü, Sülen Sarioğlu, Funda Obuz, İlhan Öztop, İlknur B. Görken, Selman Sökmen. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer. Nuclear Medicine Communications 2015; 36(9): 898 doi: 10.1097/MNM.0000000000000342
|
| 40 |
Yulia Kundel, Nicola J. Nasser, Lea Rath-Wolfson, Ofer Purim, Natalia Yanichkin, Ronen Brenner, Tanya Zehavi, Yuval Nardi, Eyal Fenig, Aaron Sulkes, Baruch Brenner. Molecular Predictors of Response to Neoadjuvant Chemoradiation for Rectal Cancer. American Journal of Clinical Oncology 2018; 41(6): 613 doi: 10.1097/COC.0000000000000337
|
| 41 |
Gaya Spolverato, Salvatore Pucciarelli, Roberta Bertorelle, Anita De Rossi, Donato Nitti. Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy. Cancers 2011; 3(2): 2176 doi: 10.3390/cancers3022176
|
| 42 |
Carlos Fernández-Martos, Miquel Nogué, Paloma Cejas, Víctor Moreno-García, Ana Hernández Machancoses, Jaime Feliu. The Role of Capecitabine in Locally Advanced Rectal Cancer Treatment. Drugs 2012; 72(8): 1057 doi: 10.2165/11633870-000000000-00000
|
| 43 |
Daniel Vallböhmer, Andreas Krieg, Nikolas H Stoecklein, Wolfram T Knoefel. Response prediction in the multimodality therapy of locally advanced rectal cancer. Colorectal Cancer 2012; 1(1): 49 doi: 10.2217/crc.11.5
|
| 44 |
Mohamed A. Hashem, Sara B.A. Shoeeb, Yasmina M. Abd-Elhakim, Wafaa A.M. Mohamed. The antitumor activity of Arthrospira platensis and/or cisplatin in a murine model of Ehrlich ascites carcinoma with hematinic and hepato-renal protective action. Journal of Functional Foods 2020; 66: 103831 doi: 10.1016/j.jff.2020.103831
|
| 45 |
Toshiyuki Suzuki, Sotaro Sadahiro, Akira Tanaka, Kazutake Okada, Gota Saito, Akemi Kamijo, Takeshi Akiba, Shuichi Kawada. Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy. International Journal of Clinical Oncology 2015; 20(6): 1130 doi: 10.1007/s10147-015-0822-7
|
| 46 |
Nara Rosana Andrade, Celina Tizuko Fujiyama Oshima, Thiago Simão Gomes, Ricardo Artigiani Neto, Nora Manoukian Forones. Imunoexpression of Ki-67 and p53 in Rectal Cancer Tissue After Treatment with Neoadjuvant Chemoradiation. Journal of Gastrointestinal Cancer 2011; 42(1): 34 doi: 10.1007/s12029-010-9225-1
|
| 47 |
Tat’yana V. Zenukova, A. G Perevoschikov, D. V Kuzmichev, Yu. A Barsukov. The indicators of the tumour proliferative activity and therapeutic responsiveness in adenocarcinoma in anal canal after complex treatment. Russian Journal of Oncology 2014; 19(5): 42 doi: 10.17816/onco40119
|
| 48 |
Mohamed L. Salem, Nahla M. Shoukry, Wafaa K. Teleb, Mohamed M. Abdel-Daim, Mohamed A. Abdel-Rahman. In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-2269-3
|
| 49 |
Ming-Yii Huang, Chan-Han Wu, Chun-Ming Huang, Fu-Yen Chung, Ching-Wen Huang, Hsiang-Lin Tsai, Chin-Fan Chen, Shiu-Ru Lin, Jaw-Yuan Wang. DPYD,TYMS,TYMP,TK1, andTK2Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/931028
|
| 50 |
Chiara Dalle Fratte, Silvia Mezzalira, Jerry Polesel, Elena De Mattia, Antonio Palumbo, Angela Buonadonna, Elisa Palazzari, Antonino De Paoli, Claudio Belluco, Vincenzo Canzonieri, Giuseppe Toffoli, Erika Cecchin. A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2021; 28(9): 847 doi: 10.3727/096504021X16232280278813
|
| 51 |
Ravindri Jayasinghe, Umesh Jayarajah, Sanjeewa Seneviratne. Biomarkers in Medicine. 2022; : 113 doi: 10.2174/9789815040463122010008
|
| 52 |
Nathalie Guedj, Frédéric Bretagnol, Pierre-Emmanuel Rautou, Lydia Deschamps, Dominique Cazals-Hatem, Pierre Bedossa, Yves Panis, Anne Couvelard. Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas. Human Pathology 2011; 42(11): 1702 doi: 10.1016/j.humpath.2011.01.015
|
| 53 |
Liam Poynter, Dieter Galea, Kirill Veselkov, Alexander Mirnezami, James Kinross, Jeremy Nicholson, Zoltán Takáts, Ara Darzi, Reza Mirnezami. Network Mapping of Molecular Biomarkers Influencing Radiation Response in Rectal Cancer. Clinical Colorectal Cancer 2019; 18(2): e210 doi: 10.1016/j.clcc.2019.01.004
|
| 54 |
Nam Kyu Kim, Hyuk Hur. New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer. Yonsei Medical Journal 2015; 56(6): 1461 doi: 10.3349/ymj.2015.56.6.1461
|